deltatrials

Major depressive disorder Trials in Philadelphia, United States

Conditions / Major depressive disorder / Philadelphia, United States

Clinical trials for Major depressive disorder investigate a range of treatment strategies and patient populations.

102 total trials for this combination

Showing top 10 of 102 trials

Trials

NCT ID Title Status Phase
NCT00234195 Wellbutrin XL, Major Depressive Disorder and Breast Cancer COMPLETED PHASE4
NCT04855747 A Study to Assess the Efficacy and Safety of REL-1017 as Adjunctive Treatment for Major Depressive Disorder (MDD) TERMINATED PHASE3
NCT01085812 Relapse-Prevention Study With Levomilnacipran ER (F2695 SR) in Patients With Major Depressive Disorder COMPLETED PHASE3
NCT01436175 SPD489 Adult Major Depressive Disorder (MDD) Open-label Safety and Tolerability Rollover Extension Study TERMINATED PHASE3
NCT06011577 Randomized, Double-Blind, Placebo-Controlled Trial of REL-1017 as Adjunctive Treatment for MDD TERMINATED PHASE3
NCT03288714 Adaptive Design Study of NEST sTMS in Subjects With Major Depressive Disorder COMPLETED NA
NCT04019704 A Trial of AXS-05 in Patients With Major Depressive Disorder COMPLETED PHASE3
NCT01692574 Treatment for Depressed, Obese Individuals at Risk for Cardiovascular Disease (CVD) COMPLETED NA
NCT04039022 Open-Label Safety Study of AXS-05 in Subjects With Depression COMPLETED PHASE3
NCT00006286 Treatment for Adolescents With Depression Study (TADS) COMPLETED PHASE3

Related Pages